TY - JOUR
T1 - Evaluating the clinical impact of resuscitative endovascular balloon occlusion of the aorta in patients with blunt trauma with hemorrhagic shock and coexisting traumatic brain injuries
T2 - a retrospective cohort study
AU - Hsu, Chih Po
AU - Liao, Chien An
AU - Wang, Chia Cheng
AU - Huang, Jen Fu
AU - Cheng, Chi Tung
AU - Chen, Szu An
AU - Tee, Yu San
AU - Kuo, Ling Wei
AU - Ou Yang, Chun Hsiang
AU - Liao, Chien Hung
AU - Fu, Chih Yuan
N1 - Publisher Copyright:
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc.
PY - 2024/10/1
Y1 - 2024/10/1
N2 - BACKGROUND: The impact of resuscitative endovascular balloon occlusion of the aorta (REBOA) on traumatic brain injuries remains uncertain, with potential outcomes ranging from neuroprotection to exacerbation of the injury. The study aimed to evaluate consciousness recovery in patients with blunt trauma, shock, and traumatic brain injuries. MATERIAL AND METHODS: Data were obtained from the American College of Surgeons Trauma Quality Improvement Program from 2017 to 2019. During the study period, 3 138 896 trauma registries were examined, and 16 016 adult patients with blunt trauma, shock, and traumatic brain injuries were included. Among these, 176 (1.1%) underwent REBOA. Comparisons were conducted between patients with and without REBOA after implementing 1:3 propensity score matching to mitigate disparities. The primary outcome was the highest Glasgow Coma Scale (GCS) score during admission. The secondary outcomes encompassed the volume of blood transfusion, the necessity for hemostatic interventions and therapeutic neurosurgery, and the mortality rate. RESULTS: Through well-balanced propensity score matching, a notable difference in mortality rate was observed, with 59.7% in the REBOA group and 48.7% in the non-REBOA group ( P =0.015). In the REBOA group, the median 4 h red blood cell transfusion was significantly higher (2800 ml [1500-4908] vs. 1300 ml [600-2500], P <0.001). The REBOA group required lesser hemorrhagic control surgeries (31.8 vs. 47.7%, P <0.001). The incidence of therapeutic neurosurgery was 5.1% in the REBOA group and 8.7% in the non-REBOA group ( P =0.168). Among survivors in the REBOA group, the median highest GCS score during admission was significantly greater for both total (11 [8-14] vs. 9 [6-14], P =0.036) and motor components (6 [4-6] vs. 5 [4-6], P =0.037). The highest GCS score among the survivors with predominant pelvic injuries was not different between the two groups (11 [8-13] vs. 11 [7-14], P =0.750). CONCLUSIONS: Patients experiencing shock and traumatic brain injury have high mortality rates, necessitating swift resuscitation and prompt hemorrhagic control. The use of REBOA as an adjunct for bridging definitive hemorrhagic control may correlate with enhanced consciousness recovery.
AB - BACKGROUND: The impact of resuscitative endovascular balloon occlusion of the aorta (REBOA) on traumatic brain injuries remains uncertain, with potential outcomes ranging from neuroprotection to exacerbation of the injury. The study aimed to evaluate consciousness recovery in patients with blunt trauma, shock, and traumatic brain injuries. MATERIAL AND METHODS: Data were obtained from the American College of Surgeons Trauma Quality Improvement Program from 2017 to 2019. During the study period, 3 138 896 trauma registries were examined, and 16 016 adult patients with blunt trauma, shock, and traumatic brain injuries were included. Among these, 176 (1.1%) underwent REBOA. Comparisons were conducted between patients with and without REBOA after implementing 1:3 propensity score matching to mitigate disparities. The primary outcome was the highest Glasgow Coma Scale (GCS) score during admission. The secondary outcomes encompassed the volume of blood transfusion, the necessity for hemostatic interventions and therapeutic neurosurgery, and the mortality rate. RESULTS: Through well-balanced propensity score matching, a notable difference in mortality rate was observed, with 59.7% in the REBOA group and 48.7% in the non-REBOA group ( P =0.015). In the REBOA group, the median 4 h red blood cell transfusion was significantly higher (2800 ml [1500-4908] vs. 1300 ml [600-2500], P <0.001). The REBOA group required lesser hemorrhagic control surgeries (31.8 vs. 47.7%, P <0.001). The incidence of therapeutic neurosurgery was 5.1% in the REBOA group and 8.7% in the non-REBOA group ( P =0.168). Among survivors in the REBOA group, the median highest GCS score during admission was significantly greater for both total (11 [8-14] vs. 9 [6-14], P =0.036) and motor components (6 [4-6] vs. 5 [4-6], P =0.037). The highest GCS score among the survivors with predominant pelvic injuries was not different between the two groups (11 [8-13] vs. 11 [7-14], P =0.750). CONCLUSIONS: Patients experiencing shock and traumatic brain injury have high mortality rates, necessitating swift resuscitation and prompt hemorrhagic control. The use of REBOA as an adjunct for bridging definitive hemorrhagic control may correlate with enhanced consciousness recovery.
UR - http://www.scopus.com/inward/record.url?scp=85213596467&partnerID=8YFLogxK
U2 - 10.1097/JS9.0000000000001823
DO - 10.1097/JS9.0000000000001823
M3 - 文章
C2 - 38874490
AN - SCOPUS:85213596467
SN - 1743-9191
VL - 110
SP - 6676
EP - 6683
JO - International journal of surgery (London, England)
JF - International journal of surgery (London, England)
IS - 10
ER -